Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | SLDB | RANI | ||
| Company | Urogen Pharma Ltd | Solid Biosciences Inc | Rani Therapeutics Holdings Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.66 | 9.03 | 6.76 | ||
| High | 14.76 | 9.28 | 7.34 | ||
| Low | 14.19 | 8.54 | 6.35 | ||
| Last | 14.21 | 8.77 | 6.99 | ||
| Change | -0.32 | -0.34 | +0.30 | ||
| % Change | -2.20% | -3.73% | +4.48% | ||
| Volume | 97,000 | 138,400 | 138,400 | ||
| 20-Day Average Volume | 305,340 | 219,030 | 238,950 | ||
| Previous Close | 14.53 | 9.11 | 6.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.10 | 10.96 | 4.94 | ||
| 20-Day Raw Stochastic | 55.76% | 3.53% | 69.55% | ||
| 20-Day Relative Strength | 45.59% | 38.80% | 66.96% | ||
| Weighted Alpha | -35.15 | -7.61 | +47.21 | ||
| Today's Opinion | 24% Sell | 40% Buy | 100% Buy | ||
| Previous Opinion | 24% Sell | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.21% since 04/17/24 | -12.21% since 04/17/24 | -10.96% since 04/17/24 | ||
| Low | 13.17 on 04/19/24 | 8.54 on 04/24/24 | 5.50 on 04/19/24 | ||
| High | 14.85 on 04/23/24 | 9.89 on 04/18/24 | 7.81 on 04/18/24 | ||
| 1-Month | |||||
| %Chg | -9.84% since 03/22/24 | -36.22% since 03/22/24 | +114.42% since 03/22/24 | ||
| Low | 12.37 on 04/11/24 | 8.54 on 04/24/24 | 2.85 on 03/26/24 | ||
| High | 18.23 on 03/25/24 | 15.05 on 03/28/24 | 8.75 on 04/17/24 | ||
| 3-Month | |||||
| %Chg | -5.52% since 01/24/24 | +12.87% since 01/24/24 | +84.43% since 01/24/24 | ||
| Low | 12.37 on 04/11/24 | 5.40 on 02/01/24 | 2.85 on 03/26/24 | ||
| High | 19.87 on 02/16/24 | 15.05 on 03/28/24 | 8.75 on 04/17/24 | ||
| 6-Month | |||||
| %Chg | +23.03% since 10/24/23 | +309.81% since 10/24/23 | +249.50% since 10/24/23 | ||
| Low | 10.63 on 10/30/23 | 1.81 on 10/30/23 | 1.82 on 11/02/23 | ||
| High | 19.87 on 02/16/24 | 15.05 on 03/28/24 | 8.75 on 04/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 340,787 | 344,668 | 335,550 | ||
| Shares Outstanding, K | 23,454 | 37,834 | 50,157 | ||
| Annual Sales | 82,710,000 | 0 | 0 | ||
| Annual Net Income | -102,240,000 | -96,020,000 | -33,970,000 | ||
| Last Quarter Sales | 23,530,000 | 0 | 0 | ||
| Last Quarter Net Income | -26,020,000 | -20,340,000 | -7,100,000 | ||
| 60-Month Beta | 1.07 | 1.93 | 0.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/14/24 | -1.00 on 03/13/24 | -0.27 on 03/20/24 | ||
| Latest Earnings Date | 05/09/24 | 05/09/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||